Singer to take the stage at Coca-Cola Arena on December 14
The drug developed by pharmaceutical giant Merck is known as anacetrapib and showed significant decreases in “bad” cholesterol and likewise boosted “good” cholesterol levels.
The study, which has also been published in the New England Journal of Medicine, showed drops in LDL levels of cholesterol of 40 percent, while good cholesterol, or HDL levels, were lifted by 138 percent.
“These results are promising and serve as the basis for our decision to further develop anacetrapib,” said Michael Mendelsohn, a lead doctor at Merck Research Laboratories.
“We look forward to continuing to study anacetrapib in a large cardiovascular clinical outcomes trial.”
The company next aims to launch a 30,000 patient study over several years to determine the drug’s effects over a wider sample of the population, and will monitor if the drug can reduce the risk of heart attack and stroke.
The 76-week study just completed showed a two-percent death rate due to cardiac arrest or stroke in patients treated with the drug, compared to 2.6 percent who took a placebo, Merck said.
The trial did not analyze the drug’s effects on blood pressure, a problem that forces US lab Pfizer to abandon its bid in 2006 to develop a similar drug.
Singer to take the stage at Coca-Cola Arena on December 14
Rajinikanth's daughter Soundarya visited the Tiruvottiyur Shri Vadivudai Amman Temple in Chennai to offer prayers for the speedy recovery of her father
Recently, both actresses visited Kashmir to shoot for the film
IMF chief said the region remains a bright spot despite numerous shocks over the past few years
The cyber-thriller is available for streaming on Netflix
'Music is a more honest place for me where I feel like I can say things that I wouldn't say,' admits the star
Last month, she was banned from being a charity trustee for five years
The authority also seized ready-to-use marijuana that was being stored with the intention of selling in the country